These results are in line with data from the Repository for Molecular Brain Neoplasia Database (Rembrandt), which described a significantly higher expression of ODZ1 in grade IV gliomas (with worse prognosis) than in grade III gliomas. This evidence concerns the gene TENM1 and central nervous system cancer.